Table 2.

Exclusion criteria

1	Enrollment in another study with an active treatment arm
2	Severe cardiovascular event (e.g., myocardial infarction, open heart surgery, stroke, CRT implantation) in the 2 months prior to admission
3	Therapy-refractory heart failure in ACC/AHA stage D or new therapies that have taken place or are planned in the next 12 months (e.g., implantation of a left ventricular assist system / transplantation)
4	Active infection
5	History of recurrent (> 1 episode) pulmonary embolism and/or deep vein thrombosis
6	Continuous or intermittent chronic inotropic therapy
7	Estimated glomerular filtration rate (eGFR) < 25 ml/min
8	Life expectancy (according to the study physician's assessment) < 12 months
9	Severe, unrepaired congenital heart defect that would prevent implantation of the sensor
10	Severe valve vitium with planned intervention in the next 3 months
11	Presence of a mechanical right heart valve
12	Mental disorder that presumably (in the opinion of the study physician) has a negative impact on patient compliance or consent
13	Failure of the coordinating physician to approve if the patient is enrolled in an HF disease management program or comparable case management programa
14	Women of childbearing age with a positive pregnancy test at the time of inclusion